Wed.Apr 22, 2020

article thumbnail

The Language of “Recovery” in the Age of COVID-19

Eye on FDA

There have been many parallels drawn between this pandemic and the AIDS pandemic that began in 1981. And in fact while many obvious differences exist there are many valid comparisons. Moreover, there are some common threads that run through crises involving a communicable disease and here were a few from this writer back in February 2020. But as many turn their attention to a “recovery” phase for this pandemic, there are also some lessons learned from the experience of HIV/AIDS that

article thumbnail

Clinical Trial Layoffs Have Begun - Covid19 Update

ECRG Media's Clinical Research Podcast

Clinical Trial Layoffs Have Begun - COVID 19 Update Layoffs are finally here for the Clinical Trials Industry, many people thought it wouldnt happen but it has to happen for CROs to stay in business. Find out more in this deep dive into the first layoffs and changes that have hit the industry. Don't forget to Subscribe for new content! Subscribe: [link] Call or Text: 910-502-3732 Email: eliteclinicalgroup@gmail.com Podcast: [link] Steemit: [link] Advertise: eliteclinicalgroup@gmail.com Watch: »

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

XenoGesis wins prestigious Queen’s Award for Enterprise in recognition of export growth

Drug Discovery Today

Nottingham-based leading independent DMPK provider, XenoGesis, has been awarded the prestigious Queen’s Award for Enterprise, International Trade, in recognition of its outstanding year-on-year export growth.

40
article thumbnail

Clinical Trial Layoffs Have Begun - Covid19 Update

ECRG Media's Clinical Research Podcast

Clinical Trial Layoffs Have Begun - COVID 19 Update. Layoffs are finally here for the Clinical Trials Industry, many people thought it wouldnt happen but it has to happen for CROs to stay in business. Find out more in this deep dive into the first layoffs and changes that have hit the industry. Don't forget to Subscribe for new content! Subscribe: [link] Call or Text: 910-502-3732 Email: eliteclinicalgroup@gmail.com Podcast: [link] Steemit: [link] Advertise: eliteclinicalgroup@gmail.com Watch: »

article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

Mogrify and Sangamo announce collaboration and exclusive license agreement for Mogrify’s iPSC- and ESC-derived regulatory T cells

Drug Discovery Today

Cambridge, UK, and Brisbane, CA, 21 April 2020 Mogrify Ltd (Mogrify®), a UK company aiming to transform the development of cell therapies by the systematic discovery of novel cell conversions, and Sangamo Therapeutics (Sangamo) (Nasdaq: SGMO), a genomic medicine company, today announced that they have executed a collaboration and exclusive license agreement for Sangamo to develop allogeneic cell therapies from Mogrify’s proprietary induced pluripotent stem cells (iPSCs) and embryonic stem cells

article thumbnail

Goodfellow’s ‘Mr. Material’ app tests scientific knowledge during lockdown

Drug Discovery Today

Looking for new ways to test your knowledge during the lockdown? Leading global supplier of research materials, Goodfellow, has recently updated its Mr. Material game, a free educational app which tests the extent of your periodic table knowledge.